The New York Genome Center (NYGC) and IBM are working on a new initiative to accelerate genomic medicine with the use of IBM’s Watson cognitive system, both organizations announced today. IBM and NYGC will test a unique Watson prototype designed specifically for genomic research as a tool to help oncologists deliver more personalized care to brain cancer patients. NYGC and its medical partner institutions plan to initially evaluate Watson’s ability to help oncologists develop ...

REGISTER NOW TO ACCESS THIS ARTICLE

All registered users get access to premium content on POWER IT Pro for free.

Already registered? here.